tradingkey.logo

Caris Life Sciences Inc

CAI
30.902USD
-0.278-0.89%
Horarios del mercado ETCotizaciones retrasadas 15 min
8.69BCap. mercado
PérdidaP/E TTM

Caris Life Sciences Inc

30.902
-0.278-0.89%

Más Datos de Caris Life Sciences Inc Compañía

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Información de Caris Life Sciences Inc

Símbolo de cotizaciónCAI
Nombre de la empresaCaris Life Sciences Inc
Fecha de salida a bolsaJun 18, 2025
Director ejecutivoMr. David Dean Halbert
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección750 West John Carpenter Freeway
CiudadIRVING
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal75039
Teléfono18667718946
Sitio Webhttps://www.carislifesciences.com/
Símbolo de cotizaciónCAI
Fecha de salida a bolsaJun 18, 2025
Director ejecutivoMr. David Dean Halbert

Ejecutivos de Caris Life Sciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--
Dr. Lloyd B. Minor, M.D.
Dr. Lloyd B. Minor, M.D.
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
178.18M
98.22%
International
3.22M
1.78%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
Otro
33.18%
Accionistas
Accionistas
Proporción
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
Otro
33.18%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
48.41%
Investment Advisor
19.16%
Private Equity
10.55%
Hedge Fund
10.43%
Investment Advisor/Hedge Fund
5.41%
Pension Fund
0.56%
Sovereign Wealth Fund
0.13%
Research Firm
0.05%
Otro
5.30%

Participación institucional

Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
166
130.17M
46.29%
+128.70M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Halbert (David D)
122.76M
43.65%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.67%
+24.39M
--
Jun 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.2%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.69%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.61%
+10.14M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
8.61M
3.06%
+8.61M
--
Jun 30, 2025
Braidwell LP
7.32M
2.6%
+7.32M
--
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.30M
2.6%
+7.30M
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.76M
2.4%
+6.76M
--
Jun 30, 2025
Neuberger Berman, LLC
6.24M
2.22%
+6.24M
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
ARK Genomic Revolution ETF
0.71%
Texas Capital Texas Small Cap Equity Index ETF
0.5%
Renaissance IPO ETF
0.49%
RiverNorth Patriot ETF
0.38%
Franklin Genomic Advancements ETF
0.16%
Invesco Russell 1000 Equal Weight ETF
0.08%
Texas Capital Texas Equity Index ETF
0.05%
T Rowe Price Small-Mid Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0.02%
iShares Global Equity Factor ETF
0.01%
Ver más
ARK Genomic Revolution ETF
Proporción0.71%
Texas Capital Texas Small Cap Equity Index ETF
Proporción0.5%
Renaissance IPO ETF
Proporción0.49%
RiverNorth Patriot ETF
Proporción0.38%
Franklin Genomic Advancements ETF
Proporción0.16%
Invesco Russell 1000 Equal Weight ETF
Proporción0.08%
Texas Capital Texas Equity Index ETF
Proporción0.05%
T Rowe Price Small-Mid Cap ETF
Proporción0.05%
Fidelity Nasdaq Composite Index ETF
Proporción0.02%
iShares Global Equity Factor ETF
Proporción0.01%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI